Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
13.07
-0.61 (-4.46%)
At close: Jul 24, 2026, 4:00 PM EDT
13.33
+0.26 (1.99%)
After-hours: Jul 24, 2026, 7:46 PM EDT
Corvus Pharmaceuticals Market Cap
Corvus Pharmaceuticals has a market cap or net worth of $1.1 billion as of July 24, 2026. Its market cap has increased by 205.21% in one year.
Market Cap
1.10B
Enterprise Value
863.18M
1-Year Change
205.21%
Ranking
Category
Stock Price
$13.07
ChartMarket Cap Chart
Since March 23, 2016, Corvus Pharmaceuticals's market cap has increased from $290.80M to $1.10B, an increase of 277.94%. That is a compound annual growth rate of 13.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 1.10B | 91.11% |
| Dec 31, 2025 | 575.10M | 67.28% |
| Dec 31, 2024 | 343.80M | 298.38% |
| Dec 29, 2023 | 86.30M | 117.93% |
| Dec 30, 2022 | 39.60M | -64.71% |
| Dec 31, 2021 | 112.20M | 12.31% |
| Dec 31, 2020 | 99.90M | -37.56% |
| Dec 31, 2019 | 160.00M | 48.84% |
| Dec 31, 2018 | 107.50M | -50.69% |
| Dec 29, 2017 | 218.00M | -27.09% |
| Dec 30, 2016 | 299.00M | 2.82% |
| Mar 23, 2016 | 290.80M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibrx Biosciences | 1.26B |
| Ardelyx | 1.25B |
| Immatics | 1.25B |
| MannKind | 1.19B |
| Jade Biosciences | 1.18B |
| Alpha Tau Medical | 1.17B |
| Seaport Therapeutics | 1.14B |
| MeiraGTx Holdings | 1.13B |